中泰证券股份有限公司 关于 绍兴贝斯美化工股份有限公司 重大资产购买暨关联交易 之 2024 年度持续督导报告书 暨持续督导总结报告 独立财务顾问 二〇二五年四月 1 独立财务顾问声明 中泰证券股份有限公司作为绍兴贝斯美化工股份有限公司重大资产购买暨 关联交易的独立财务顾问，根据《公司法》《证券法》《重组管理办法》《上市 公司并购重组财务顾问业务管理办法》等法律法规的有关规定，按照证券行业公 认的业务标准、道德规范，本着诚实信用、勤勉尽责的态度，经过审慎核查，出 具本持续督导意见暨持续督导总结报告（以下简称"本持续督导意见"）。 本持续督导意见所依据的文件和材料由交易各方提供。本次交易各方保证其 所提供的有关本次重组的相关信息真实、准确和完整，没有虚假记载、误导性陈 述或者重大遗漏，并对所提供信息的真实性、准确性、完整性负责。 本持续督导意见中，除非另有所指，下列简称具有如下含义： | 公司、贝斯美、上市 | 指 | 绍兴贝斯美化工股份有限公司 | | --- | --- | --- | | 公司 | | | | 独立财务顾问/中泰证 | 指 | 中泰证券股份有限公司 | | 券 | | | | 标的公司、捷 ...

中泰证券股份有限公司 关于绍兴贝斯美化工股份有限公司 持续督导保荐总结报告书 中泰证券股份有限公司（以下简称"中泰证券"、"保荐机构"）作为绍兴 贝斯美化工股份有限公司（以下简称"贝斯美"、"上市公司"、"公司"）首 次公开发行股票和向特定对象发行股票的持续督导机构，持续督导职责期限至 2024 年 12 月 31 日。目前，持续督导期限已经届满。中泰证券根据《证券发行 上市保荐业务管理办法》《深圳证券交易所创业板股票上市规则》等有关规定， 出具本持续督导保荐总结报告书，具体情况如下： 一、保荐机构及保荐代表人承诺 1、保荐总结报告书和证明文件及其相关资料的内容不存在虚假记载、误导性 陈述或重大遗漏，保荐机构及保荐代表人对其真实性、准确性、完整性承担法律 责任。 2、本保荐机构及本人自愿接受中国证监会对保荐总结报告书相关事项进行 的任何质询和调查。 3、本保荐机构及本人自愿接受中国证监会按照《证券发行上市保荐业务管理 办法》的有关规定采取的监管措施。 | 情况 | 内容 | | --- | --- | | 保荐机构名称 | 中泰证券股份有限公司 | | 注册地址 | 山东省济南市经七路 86 号 | | 办公 ...

Group 1: Company Overview and Strategic Projects - Shaoxing Bestmay Chemical Co., Ltd. is actively expanding its product lines in the C5 chemical sector, including the "Annual Production of 8,500 Tons of Ketone Series Green New Materials Project" and the "Annual Production of 12,100 Tons of Cyclopentane Series Green New Materials Project" [1][2][3] - The company has achieved stable operation of its ketone facility, with product quality meeting standards and sales status being steady [2][3] - The company is positioned as a leader in the domestic C5 comprehensive utilization field, enhancing its product offerings and reducing reliance on imports [2][3] Group 2: Financial Performance and Growth - In 2024, the company reported a revenue of 1.328 billion RMB, representing a year-on-year growth of 89.97% due to the full-year consolidation of Ningbo Jielike's operations following an 80% stake acquisition [5][6] - The revenue from C5 series products increased from 11.67 million RMB in 2023 to 73.12 million RMB in 2024, marking a growth of 5.26 times [20] Group 3: Research and Development - The company invested 45.52 million RMB in R&D in 2024, a 13.7% increase from the previous year, and holds 58 authorized patents, including 32 invention patents [6][8] - The focus on R&D has led to the development of proprietary technologies that enhance production efficiency and reduce costs, such as low-temperature continuous nitration and solid salt recovery technologies [18] Group 4: Market Position and Competitive Advantage - The company is recognized as a national high-tech enterprise and has established a complete production and R&D capability for the herbicide Dimethenamid-P, covering the entire industry chain from intermediates to formulations [8][15] - The company has a strong export presence, with its subsidiary Jielike operating in 79 countries, achieving over 75% of its revenue from overseas markets in 2024 [15][19] Group 5: Future Outlook and Strategic Initiatives - The company plans to continue focusing on environmentally friendly pesticide development and expand its C5 new materials product line to enhance market share and profitability [5][15] - The company aims to leverage its existing market channels and the acquisition of Jielike to penetrate emerging markets in South America, Africa, and Southeast Asia, thereby increasing sales of Dimethenamid-P [11][15]

Core Viewpoint - The company is actively advancing its projects in the green materials sector, particularly focusing on the production of specialized alcohols and cyclopentane, while also addressing financial strategies to manage costs and enhance profitability [1][2][3][4][5][6]. Project Progress - The "Annual Production of 20,000 Tons of Specialized Alcohol Series Green Materials Project" is currently in the construction phase and progressing smoothly [1]. - The "Annual Production of 12,100 Tons of Cyclopentane Series Green Materials Project" has entered trial production, with an investment of 58.31 million yuan, achieving 48.18% completion [2]. - The cyclopentane project is expected to effectively extend the company's carbon five industrial chain and improve market competitiveness [2][3]. Financial Performance - The company's revenue for 2024 reached 1.328 billion yuan, a year-on-year increase of 89.97%, primarily due to the full-year consolidation of the acquired subsidiary, Ningbo Jielike [21]. - The company is implementing cost optimization strategies, including self-supply of key raw materials like 3-pentanone, which is expected to lower production costs for its dimethyl pentyl herbicide [3][4]. Market Strategy - The company is focusing on expanding its overseas market presence, with over 75% of its revenue expected to come from international sales in 2024 [3][4]. - The acquisition of Jielike is anticipated to enhance the company's market position and sales scale in the dimethyl pentyl herbicide sector, leveraging its established channels in 79 countries [10][24]. Research and Development - The company has increased its R&D investment, with expenses totaling 45.52 million yuan in 2024, a 13.7% increase from the previous year [20]. - The company holds 58 authorized patents, including 32 invention patents, which support its competitive edge in the agricultural and new materials sectors [20][19]. Product Development - The cyclopentane production is stable, and the products are being sold in bulk, contributing to the company's revenue growth [3][22]. - The company is also exploring high-value applications for its carbon five new materials, including optical materials and pharmaceutical intermediates [16][25].

贝斯美（300796）发布2024年度报告与2025年一季度报告。2024年公司全年实现营收13.28亿元，同比 增长89.97%，公司多项产品营收有大幅增长。 2025年一季度，贝斯美在2024年营收高速增长基础上再创佳绩，公司一季度实现营收4.26亿元，同比增 长19.35%；扣非净利润2,408.31万元，同比增长32.92%。随着新建产线产能逐步释放，贝斯美在绿色新 材料领域的战略布局已初显成效。面对日益严格的全球环保政策及持续攀升的绿色化学品市场需求，贝 斯美凭借技术领先地位与市场议价能力，有望进一步巩固行业竞争优势，实现业绩稳健增长。 全产业链优势赋能，技术创新驱动高质量发展 面对激烈行业竞争，贝斯美凭借显著产业链竞争优势脱颖而出。公司利用大宗化工原料邻二甲苯，通过 低温连续硝化工艺高效合成4-硝基邻二甲苯，并以自产的4-硝为原料进一步合成二甲戊灵的关键中间体 戊胺。随着铜陵"年产8,500吨戊酮系列绿色新材料项目"的投产，贝斯美成功实现二甲戊灵另一重要原 料3-戊酮的自给自足。各中间体产能充分匹配，完全满足公司二甲戊灵原药的生产需求，显著增强贝斯 美成本控制能力和市场竞争力。报告期内，贝斯美中间 ...

2024 年贝斯美公司实现收入约 13.228 亿元，但总体净利润亏损，归母净利 润为负 3,280 万元。亏损主要原因在于铜陵贝斯美子公司的试生产和生产调整 状态，全年亏损 7,700 万元。此外，二甲戊灵业务处于去库存周期，下游需求 量和价格较前期有所下滑。具体来看，公司三大业务板块中，二甲戊灵原药业 务虽然有所下滑，但仍实现利润 3,000 多万元；宁波杰力克农药出海业务实现 营业收入约 7.5 亿元，净利润 3,500 万元；铜陵贝斯美碳五业务经历两次技改， 总体开工率和产能利用率较低，全年亏损 7,700 万元。2025 年一季度，公司 延续装置向好的状态，实现利润 2,600 万元。 • 贝斯美对赌目标为 2025 年净利润达到 4,000 万元以上。公司通过自产三 氧化二钨铜降低二甲戊灵成本，每吨成本下降约 3,000 元。环戊烷装置利 用碳五项目一期生产的环戊烯，提升产品附加值。 • 贝斯美未来将专注主营业务，积极转型，推进碳五业务发展，并结合杰力 克销售渠道拓展农药出海业务。公司计划将回购股份用于股权激励方案， 并积极进行转型。 贝斯美 2025042120250416 摘要 • 贝斯美 2 ...

上 市 公 司 基础化工 —— Q1 业绩环比实现扭亏，农药板块业务景气底部回 暖，C5 项目逐步贡献增量 报告原因：有业绩公布需要点评 增持（维持） | 市场数据： | 2025 年 04 月 21 日 | | --- | --- | | 收盘价（元） | 9.69 | | 一年内最高/最低（元） | 17.27/8.10 | | 市净率 | 2.0 | | 息率（分红/股价） | 0.41 | | 流通 A 股市值（百万元） | 3,499 | | 上证指数/深证成指 | 3,291.43/9,905.53 | | 注："息率"以最近一年已公布分红计算 | | | 基础数据: 2025 年 03 月 31 日 | | | --- | --- | | 每股净资产（元） | 4.80 | | 资产负债率% | 43.99 | | 总股本/流通 A 股（百万） | 361/361 | | 流通 B 股/H 股（百万） | -/- | 一年内股价与大盘对比走势： 04-22 05-22 06-22 07-22 08-22 09-22 10-22 11-22 12-22 01-22 02-22 03-22 -60% ...

证券代码：300796 证券简称：贝斯美 公告编号：2025-035 绍兴贝斯美化工股份有限公司 关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、担保情况概述 绍兴贝斯美化工股份有限公司(以下简称"公司"或"贝斯美") 分别于 2024年4月19日和2024年5月10日，召开了第三届董事会第十七次会议和2023年年 度 股东大会，审议通过了《关于公司预计2024年度为子公司提供担保额度的议案》， 根据公司经营发展的需要，2024年度公司预计为公司合并报表范围内子公司银行综 合授信业务提供不超过9.7亿元人民币的担保，其中为全资子公司江苏永安化工有 限公司（以下简称江苏永安）提供的担保预计不超过1.6亿元人民币。担保额度有效 期自2023年年度股东大会审议通过之日起12个月。具体内容详见公司2024年4月20 日披露于巨潮资讯网(www.cninfo.com.cn ) 上的《关于预计2024年度为子公司提供 担保额度的公告》（公告编号2024-019）。 二、担保进展情况 近日，公司分别与华夏银行淮安分行、南京银行淮安分行 ...

Company Overview - The company is a leading enterprise in the niche market of the herbicide Dimethenamid-P, possessing a complete production and R&D system across the entire industry chain [18][19] - The main products include environmentally friendly, efficient, and low-toxicity herbicides, specifically Dimethenamid-P, which has a broad application range in various crops [18][19] Industry Analysis Pesticide Industry - The global pesticide market is experiencing weak short-term demand but has strong long-term resilience, with stable growth momentum overall [6][7] - The pesticide industry is becoming increasingly concentrated, with major international players like Syngenta, Bayer, BASF, and Corteva dominating the market, leading to greater growth opportunities for leading raw material companies [7][8] - The production capacity of pesticide raw materials is shifting from developed regions to the Asia-Pacific, fostering the development of local pesticide companies [8][9] - China has become a significant global pesticide producer, with a complete industrial system and ongoing improvements in product quality and technology [9][10] Carbon Five New Materials Industry - The global carbon five new materials market is thriving, with significant production capacity concentrated in North America, the Middle East, Northeast Asia, and Western Europe [13][14] - China is one of the largest producers of cracked carbon five, with production expected to increase significantly due to integrated refining projects [15][17] - The domestic carbon five industry is primarily focused on producing low-end products like petroleum resins and rubber, with high-value applications still in the early stages [17][18] - There is substantial potential for domestic carbon five products to replace imports, particularly in high-end applications [18][19] Financial Performance - The company has not restated or adjusted previous years' financial data, indicating stability in its financial reporting [38] - The company’s financial indicators and major accounting data are consistent with previously disclosed quarterly reports, reflecting a stable financial position [38] Market Position - The company is recognized as a leading pesticide exporter in China, with its subsidiary, Ningbo Jielike, establishing sales channels in 79 countries and regions [28][29] - The company’s agricultural products are exported to over 180 countries, with a significant increase in export volume from 145,300 tons in 2000 to 1,927,200 tons in 2022, achieving a compound annual growth rate of 12.47% [28][29]

证券代码：300796 证券简称：贝斯美 公告编号：2025-031 绍兴贝斯美化工股份有限公司 关于宁波捷力克化工有限公司2024年度业绩承诺实现情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、交易基本情况 绍兴贝斯美化工股份有限公司（以下简称"公司"或"贝斯美"）于2023年10 月20日召开第三届董事会第十三次会议、2023年11月14日召开第三届董事会第十五 次会议、2023年12月1日召开2023年第一次临时股东大会，审议通过了重大资产购买 的相关议案，公司以支付现金方式收购宁波捷力克化工有限公司（以下简称"宁波 捷力克"）剩余80%股权，具体内容详见公司刊登在巨潮资讯网《绍兴贝斯美化工股 份有限公司关于重大资产购买报告书（草案）（第二次修订稿）。 宁波捷力克已于2023年12月4日就本次交易完成了工商变更登记手续，并取得由 宁波市海曙区市场监督管理局换发的《营业执照》。本交易完成后，公司持有捷力 克100%股权，捷力克成为公司的全资子公司。具体内容详见公司刊登在巨潮资讯网 《绍兴贝斯美化工股份有限公司重大资产购买暨关联交易实施情况报 ...